NK cells and CTLs are required to clear solid tumor in a novel model of patient-derived-xenograft
D. T. Le, B. Burt, G. Van Buren, S. A. Abeynaike, C. Zalfa, R. Nikzad, F. Kheradmand, S. Paust
This study develops a novel syngeneic immune system PDX model to show that NK cells and CTLs are required for effective immunotherapy against solid tumors.
bioRxiv · May 24, 2020 · PreprintImmunology